This study will investigate the safety and efficacy of a new drug DB-1303 against standard treatment procedure in patients with metastatic breast cancer. This study will also evaluate the efficacy of a diagnostic test that will be performed during the trial.
The study involves study drug infusions, physical examinations, pulmonary function tests, tissue, blood and urine sample collections, ECG, ECHO/MUGA scan, eye examination, CT scans/MRI with or without X-rays, bone scans.
NC Cancer Hospital (Basnight)
UNC Hospitals / UNC Medical Center
101 Manning Dr, Chapel Hill, NC 27514, USA
Claire Dees
LCCC - Clinical Trials
Clinical or Medical
Interventional
Cancer (Breast)
24-0522